EFINACONAZOLE

EFINACONAZOLE was reported 1962 times

EFINACONAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DISABILITY ASSESSMENT SCALE 5 0.8333
1 STOMA SITE DERMATITIS 13 0.3939
2 ANTACID THERAPY 46 0.3538
3 APPLICATION SITE JOINT PAIN 1 0.3333
4 SLEEP DISORDER THERAPY 48 0.2424
5 CONGENITAL HIATUS HERNIA 52 0.2281
6 OBSTRUCTIVE DEFAECATION 13 0.1940
7 MALIGNANT MELANOMA STAGE 0 40 0.1914
8 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 159 0.1715
9 ANTICOAGULANT THERAPY 46 0.1620
10 ANALGESIC THERAPY 48 0.1495
11 BACTERIAL NAIL INFECTION 1 0.1429
12 ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION 10 0.1389
13 DRUG THERAPY 45 0.1327
14 APPLICATION SITE JOINT ERYTHEMA 1 0.1111
15 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 13 0.0897
16 TOTAL LUNG CAPACITY DECREASED 116 0.0726
17 APPENDICOLITH 23 0.0594
18 ADMINISTRATION SITE DRYNESS 1 0.0526
19 LUNG OPACITY 121 0.0459
20 EYE IRRIGATION 1 0.0455
21 APPLICATION SITE FISSURE 4 0.0444
22 PNEUMOCOCCAL INFECTION 26 0.0439
23 PLEURITIC PAIN 105 0.0380
24 NAIL CUTICLE FISSURE 2 0.0303
25 NAIL DEFORMATION 2 0.0299
26 RHEUMATOID FACTOR 3 0.0278
27 NAIL DISCOLOURATION 109 0.0277
28 FRACTURE PAIN 14 0.0260
29 HYPERPHOSPHATAEMIA 55 0.0256
30 AORTIC VALVE PROLAPSE 1 0.0250
31 ACQUIRED ATTR AMYLOIDOSIS 1 0.0244
32 OSTEOGENESIS IMPERFECTA 14 0.0240
33 ENCHONDROMATOSIS 2 0.0233
34 AUDITORY NERVE DISORDER 1 0.0227
35 RALES 122 0.0210
36 HEPATIC ARTERY ANEURYSM 2 0.0208
37 NAIL HYPERTROPHY 4 0.0197
38 LACK OF SATIETY 5 0.0192
39 BRONCHIECTASIS 128 0.0190
40 NAIL AVULSION 4 0.0178
41 STOMA SITE INFLAMMATION 13 0.0174
42 BLOOD CALCIUM INCREASED 152 0.0173
43 ASTEATOSIS 2 0.0169
44 DERMATOPHYTOSIS OF NAIL 2 0.0168
45 NAIL BED DISORDER 7 0.0164
46 APPLICATION SITE INJURY 3 0.0158
47 ONYCHOMYCOSIS 69 0.0157
48 APPLICATION SITE CELLULITIS 1 0.0149
49 ASPIRATION 159 0.0145
50 INGROWING NAIL 34 0.0144
51 APPLICATION SITE ODOUR 2 0.0138
52 NAIL GROWTH ABNORMAL 15 0.0136
53 EXPANDED DISABILITY STATUS SCALE 1 0.0133
54 SPUTUM DISCOLOURED 124 0.0131
55 RESPIRATORY SYMPTOM 37 0.0130
56 PATIENT DISSATISFACTION WITH TREATMENT 24 0.0124
57 BLOOD COPPER DECREASED 1 0.0122
58 CEREBROVASCULAR ARTERIOVENOUS MALFORMATION 1 0.0115
59 VESTIBULAR NEURONITIS 6 0.0112
60 OBSTRUCTIVE AIRWAYS DISORDER 125 0.0112
61 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 56 0.0110
62 BLOOD TEST ABNORMAL 148 0.0105
63 STOMA SITE PAIN 14 0.0095
64 ANTI-GAD ANTIBODY POSITIVE 1 0.0089
65 CLOSTRIDIUM DIFFICILE SEPSIS 1 0.0089
66 BREATH SOUNDS ABNORMAL 44 0.0089
67 CHOROID MELANOMA 1 0.0088
68 EFFUSION 12 0.0088
69 BENIGN PROSTATIC HYPERPLASIA 45 0.0087
70 GASTROINTESTINAL STOMA COMPLICATION 13 0.0083
71 NAIL PIGMENTATION 2 0.0083
72 BLOOD PHOSPHORUS INCREASED 22 0.0080
73 BACTEROIDES INFECTION 2 0.0077
74 APPLICATION SITE DERMATITIS 7 0.0075
75 METABOLIC ALKALOSIS 12 0.0075
76 HYPOPHOSPHATAEMIA 54 0.0073
77 ONYCHALGIA 7 0.0070
78 FALLOPIAN TUBE CANCER 1 0.0069
79 PULMONARY FIBROSIS 129 0.0067
80 TRANSAMINASES INCREASED 149 0.0067
81 UNDERWEIGHT 13 0.0066
82 BONE SEQUESTRUM 1 0.0066
83 MYASTHENIA GRAVIS 53 0.0066
84 PULMONARY MASS 97 0.0065
85 PRODUCT DROPPER ISSUE 5 0.0064
86 APPLICATION SITE VESICLES 40 0.0062
87 LOWER RESPIRATORY TRACT INFECTION VIRAL 3 0.0059
88 LIVER FUNCTION TEST INCREASED 124 0.0058
89 ONYCHOMADESIS 24 0.0057
90 NAIL RIDGING 3 0.0057
91 TROPONIN INCREASED 43 0.0056
92 IRON DEFICIENCY 25 0.0056
93 NAIL BED BLEEDING 3 0.0053
94 BLOOD PRESSURE SYSTOLIC ABNORMAL 13 0.0053
95 AORTIC STENOSIS 18 0.0052
96 APPLICATION SITE DISCOLOURATION 21 0.0052
97 NAIL DISORDER 45 0.0051
98 PRODUCT DELIVERY MECHANISM ISSUE 27 0.0050
99 ARTHROSCOPIC SURGERY 1 0.0050
100 MALIGNANT MELANOMA IN SITU 6 0.0048
101 CAROTID ENDARTERECTOMY 1 0.0048
102 HAEMOPTYSIS 126 0.0045
103 HYPERCHOLESTEROLAEMIA 42 0.0043
104 FULL BLOOD COUNT ABNORMAL 46 0.0043
105 APPLICATION SITE INFLAMMATION 6 0.0043
106 GASTROINTESTINAL STOMA OUTPUT INCREASED 2 0.0043
107 NAIL INFECTION 6 0.0042
108 HYPERLIPIDAEMIA 50 0.0042
109 ASPARTATE AMINOTRANSFERASE 1 0.0041
110 VERTIGO POSITIONAL 7 0.0040
111 NEURITIS 6 0.0039
112 APPLICATION SITE EROSION 5 0.0039
113 ONYCHOLYSIS 6 0.0038
114 CHILLBLAINS 1 0.0038
115 BLOOD URIC ACID INCREASED 22 0.0038
116 MICTURITION URGENCY 43 0.0038
117 TINEA PEDIS 6 0.0038
118 CRYSTALLURIA 2 0.0037
119 LOWER RESPIRATORY TRACT INFECTION 161 0.0035
120 HYPOXIA 124 0.0035
121 UPPER RESPIRATORY TRACT INFECTION 161 0.0035
122 APPLICATION SITE DISCHARGE 4 0.0035
123 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 59 0.0034
124 FAECES HARD 13 0.0033
125 EAR INFECTION FUNGAL 1 0.0033
126 URETHRAL HAEMORRHAGE 2 0.0033
127 ULCER 52 0.0033
128 TERMINAL ILEITIS 2 0.0033
129 BACTERIAL INFECTION 60 0.0032
130 EUGLYCAEMIC DIABETIC KETOACIDOSIS 13 0.0031
131 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
132 ONYCHOCLASIS 21 0.0030
133 CATHETER SITE BRUISE 1 0.0030
134 PRECANCEROUS CONDITION 2 0.0030
135 CYSTITIS BACTERIAL 1 0.0030
136 DETOXIFICATION 1 0.0029
137 LUMBAR VERTEBRAL FRACTURE 13 0.0028
138 APPLICATION SITE SWELLING 14 0.0028
139 GOUT 50 0.0028
140 APPLICATION SITE PAIN 61 0.0028
141 APPLICATION SITE PUSTULES 1 0.0027
142 END STAGE RENAL DISEASE 50 0.0027
143 FEEDING TUBE USER 1 0.0027
144 BLISTER RUPTURE 2 0.0027
145 COMPRESSION FRACTURE 14 0.0026
146 AMYOTROPHY 1 0.0026
147 DEATH OF RELATIVE 1 0.0025
148 APPENDICITIS 23 0.0025
149 NEURALGIA 59 0.0024
150 BLOOD CREATININE INCREASED 158 0.0024
151 MYOCARDIAL NECROSIS MARKER INCREASED 4 0.0024
152 EXPOSURE VIA EYE CONTACT 1 0.0024
153 WOUND SECRETION 9 0.0023
154 ANOGENITAL WARTS 2 0.0022
155 PRODUCT OUTER PACKAGING ISSUE 2 0.0022
156 INJECTION SITE DRYNESS 2 0.0022
157 BIOPSY BONE MARROW ABNORMAL 1 0.0022
158 JOINT INJURY 47 0.0022
159 APPLICATION SITE EXFOLIATION 9 0.0022
160 ANEURYSM RUPTURED 2 0.0022
161 VENTRICULAR FIBRILLATION 24 0.0022
162 PRECANCEROUS CELLS PRESENT 3 0.0021
163 PLEURAL EFFUSION 127 0.0021
164 FAECAL VOLUME DECREASED 1 0.0021
165 POSTOPERATIVE WOUND INFECTION 14 0.0021
166 APPLICATION SITE BRUISE 2 0.0021
167 APPLICATION SITE ACNE 1 0.0020
168 DRAINAGE 1 0.0020
169 EXOSTOSIS OF JAW 1 0.0020
170 HYPOFIBRINOGENAEMIA 2 0.0020
171 APPLICATION SITE ERYTHEMA 52 0.0020
172 APPLICATION SITE INFECTION 1 0.0020
173 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 14 0.0020
174 LACTOSE INTOLERANCE 5 0.0020
175 FULMINANT TYPE 1 DIABETES MELLITUS 2 0.0019
176 MULTIPLE ORGAN DYSFUNCTION SYNDROME 55 0.0019
177 WHEEZING 115 0.0019
178 CYST REMOVAL 1 0.0019
179 FAECAL VOLUME INCREASED 1 0.0019
180 APPLICATION SITE PAPULES 2 0.0019
181 TRAUMATIC HAEMATOMA 2 0.0019
182 DEFAECATION URGENCY 13 0.0019
183 EPHELIDES 1 0.0019
184 MUSCULOSKELETAL STIFFNESS 161 0.0018
185 APPLICATION SITE HAEMORRHAGE 5 0.0018
186 APHTHOUS ULCER 14 0.0018
187 ENDOMETRIAL THICKENING 1 0.0018
188 APPLICATION SITE DRYNESS 6 0.0018
189 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
190 EYELID DISORDER 4 0.0017
191 RHEUMATOID FACTOR POSITIVE 10 0.0017
192 GASTROOESOPHAGEAL REFLUX DISEASE 137 0.0017
193 EYE LASER SURGERY 1 0.0017
194 ALLERGY TO METALS 1 0.0016
195 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
196 INFUSION SITE WARMTH 2 0.0016
197 INTERVERTEBRAL DISC DEGENERATION 15 0.0016
198 CARDIOGENIC SHOCK 23 0.0016
199 BLISTER 89 0.0016
200 HICCUPS 13 0.0016
201 CARDIOVASCULAR DISORDER 39 0.0015
202 PRODUCT CONTAINER ISSUE 13 0.0015
203 BRONCHITIS VIRAL 1 0.0015
204 CORONARY ARTERY DISEASE 45 0.0015
205 OEDEMA PERIPHERAL 180 0.0015
206 DISCHARGE 2 0.0014
207 ASTHMA 163 0.0014
208 CHRONIC FATIGUE SYNDROME 2 0.0014
209 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0014
210 PRODUCT LEAKAGE 8 0.0014
211 SLEEP DEFICIT 3 0.0014
212 APPLICATION SITE ULCER 1 0.0014
213 SKIN WEEPING 5 0.0014
214 ANTIBODY TEST ABNORMAL 1 0.0014
215 BRAIN CONTUSION 1 0.0014
216 GENERALISED ANXIETY DISORDER 2 0.0014
217 PRECANCEROUS SKIN LESION 2 0.0014
218 ALLERGIC COUGH 1 0.0013
219 SYNOVIAL CYST 6 0.0013
220 BLISTER INFECTED 1 0.0013
221 TRANSIENT ISCHAEMIC ATTACK 43 0.0013
222 CHEMICAL INJURY 1 0.0012
223 INTESTINAL POLYP 2 0.0012
224 BRAIN FOG 19 0.0012
225 COVID-19 IMMUNISATION 1 0.0012
226 HEPATORENAL SYNDROME 2 0.0012
227 ALLERGIC SINUSITIS 1 0.0012
228 BLOOD PRESSURE FLUCTUATION 28 0.0012
229 ABDOMINAL LYMPHADENOPATHY 1 0.0012
230 APPLICATION SITE IRRITATION 14 0.0011
231 APPLICATION SITE DISCOMFORT 2 0.0011
232 ESSENTIAL HYPERTENSION 2 0.0011
233 SOFT TISSUE INFECTION 2 0.0011
234 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 57 0.0011
235 ROTATOR CUFF SYNDROME 14 0.0011
236 DRUG EFFECT INCOMPLETE 39 0.0011
237 IMMUNODEFICIENCY 16 0.0011
238 STOMA SITE ERYTHEMA 2 0.0011
239 SKIN HYPERTROPHY 3 0.0011
240 ELECTROCARDIOGRAM CHANGE 1 0.0011
241 INSURANCE ISSUE 16 0.0010
242 EPIDERMAL NECROSIS 1 0.0010
243 EYELID RASH 1 0.0010
244 DACTYLITIS 1 0.0010
245 JOINT NOISE 2 0.0010
246 VOCAL CORD DISORDER 2 0.0010
247 GENERAL PHYSICAL HEALTH DETERIORATION 116 0.0010
248 LIVER DISORDER 44 0.0010
249 TREMOR 163 0.0010
250 PNEUMONIA BACTERIAL 9 0.0010
251 HYPONATRAEMIA 55 0.0010
252 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
253 BLOOD BLISTER 3 0.0010
254 SWELLING 89 0.0009
255 DRUG ADMINISTERED AT INAPPROPRIATE SITE 10 0.0009
256 BURNS THIRD DEGREE 1 0.0009
257 APPLICATION SITE RASH 13 0.0009
258 BONE DEMINERALISATION 1 0.0009
259 APPLICATION SITE PRURITUS 21 0.0009
260 PERIODONTITIS 2 0.0009
261 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
262 PULMONARY FUNCTION TEST DECREASED 4 0.0009
263 MIDDLE EAR EFFUSION 2 0.0009
264 INABILITY TO AFFORD MEDICATION 9 0.0009
265 ANAEMIA 172 0.0009
266 FAECES PALE 2 0.0009
267 CARDIAC HYPERTROPHY 1 0.0009
268 APATHY 13 0.0009
269 SCIATICA 14 0.0009
270 CHEMICAL BURN 1 0.0009
271 PANCREATITIS CHRONIC 2 0.0008
272 SARCOIDOSIS 4 0.0008
273 BLEEDING TIME PROLONGED 1 0.0008
274 ERUCTATION 16 0.0008
275 BONE DISORDER 15 0.0008
276 ASCITES 24 0.0008
277 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
278 PLATELET DISORDER 2 0.0008
279 DERMATITIS CONTACT 9 0.0008
280 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
281 SLEEP DISORDER 55 0.0008
282 ANAL INCONTINENCE 7 0.0008
283 DIABETES MELLITUS 58 0.0008
284 POLYARTHRITIS 4 0.0008
285 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
286 LUNG DISORDER 37 0.0008
287 WEIGHT BEARING DIFFICULTY 2 0.0007
288 PRODUCT LABEL ISSUE 5 0.0007
289 BODY TEMPERATURE INCREASED 15 0.0007
290 LYMPHOEDEMA 5 0.0007
291 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
292 CARDIOVERSION 1 0.0007
293 MOUTH ULCERATION 15 0.0007
294 INFUSION SITE ERYTHEMA 6 0.0007
295 APPLICATION SITE REACTION 5 0.0007
296 CONNECTIVE TISSUE DISORDER 1 0.0007
297 INJECTION SITE SCAR 2 0.0007
298 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
299 EYELID MARGIN CRUSTING 2 0.0007
300 FEEDING DISORDER 14 0.0007
301 THROMBOSIS 55 0.0007
302 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
303 CONJUNCTIVITIS ALLERGIC 1 0.0007
304 ABDOMINAL PAIN UPPER 138 0.0007
305 CONSTIPATION 146 0.0007
306 URINE ANALYSIS ABNORMAL 2 0.0007
307 SEPSIS 74 0.0007
308 EPICONDYLITIS 1 0.0007
309 THROMBOPHLEBITIS SUPERFICIAL 2 0.0007
310 ROSACEA 3 0.0006
311 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
312 SECRETION DISCHARGE 8 0.0006
313 SKIN TIGHTNESS 3 0.0006
314 RESPIRATORY RATE DECREASED 2 0.0006
315 FUNGAL INFECTION 21 0.0006
316 POLYMYALGIA RHEUMATICA 2 0.0006
317 INTENTIONAL PRODUCT MISUSE 55 0.0006
318 HYPERSOMNIA 18 0.0006
319 RASH VESICULAR 3 0.0006
320 APPLICATION SITE BURN 3 0.0006
321 ARTHROPOD STING 1 0.0006
322 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
323 PULMONARY EMBOLISM 57 0.0006
324 FREQUENT BOWEL MOVEMENTS 16 0.0006
325 DRUG INTOLERANCE 57 0.0006
326 PRODUCT COLOUR ISSUE 3 0.0006
327 COUGH 162 0.0006
328 TENDERNESS 6 0.0006
329 BURNS SECOND DEGREE 1 0.0006
330 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
331 PRODUCT DOSE OMISSION ISSUE 166 0.0006
332 ASTHENIA 209 0.0006
333 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
334 CONDUCTION DISORDER 1 0.0005
335 PRODUCT PRESCRIBING ERROR 13 0.0005
336 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 10 0.0005
337 SEBORRHOEA 2 0.0005
338 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
339 HYPERKERATOSIS 3 0.0005
340 SKIN DISORDER 18 0.0005
341 AURA 1 0.0005
342 DISEASE RECURRENCE 25 0.0005
343 DERMATITIS 11 0.0005
344 ADRENAL DISORDER 1 0.0005
345 FEMUR FRACTURE 16 0.0005
346 ORAL INFECTION 2 0.0005
347 SKIN FISSURES 10 0.0005
348 PRODUCT USE ISSUE 96 0.0005
349 SKIN ODOUR ABNORMAL 2 0.0005
350 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
351 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
352 DRY MOUTH 41 0.0005
353 BLEPHARITIS 2 0.0005
354 OSTEOARTHRITIS 21 0.0005
355 PYREXIA 170 0.0005
356 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1 0.0005
357 CHANGE OF BOWEL HABIT 1 0.0005
358 HYPERURICAEMIA 2 0.0005
359 SKIN EXFOLIATION 41 0.0005
360 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
361 SPINAL COMPRESSION FRACTURE 4 0.0005
362 CHEST INJURY 1 0.0005
363 SUICIDAL BEHAVIOUR 2 0.0005
364 INFUSION SITE SWELLING 3 0.0005
365 MUSCLE ATROPHY 6 0.0005
366 BLOOD CHOLESTEROL INCREASED 22 0.0005
367 PNEUMONIA 152 0.0005
368 FACIAL PARALYSIS 4 0.0005
369 GASTROINTESTINAL DISORDER 42 0.0005
370 ABSCESS INTESTINAL 1 0.0005
371 ERYTHEMA 95 0.0005
372 ECONOMIC PROBLEM 7 0.0005
373 BURNING SENSATION 32 0.0005
374 COLONOSCOPY 1 0.0005
375 MALNUTRITION 5 0.0004
376 ADENOCARCINOMA 1 0.0004
377 WRONG PRODUCT ADMINISTERED 3 0.0004
378 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
379 EYE OPERATION 2 0.0004
380 CONJUNCTIVITIS 8 0.0004
381 MASS 6 0.0004
382 HEART RATE DECREASED 15 0.0004
383 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
384 ACCIDENTAL EXPOSURE TO PRODUCT 43 0.0004
385 VULVOVAGINAL PAIN 2 0.0004
386 PERIPHERAL SWELLING 63 0.0004
387 MOOD SWINGS 13 0.0004
388 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 29 0.0004
389 DERMAL CYST 1 0.0004
390 DENTAL OPERATION 1 0.0004
391 CARTILAGE INJURY 1 0.0004
392 FOOT OPERATION 2 0.0004
393 MUCOUS STOOLS 2 0.0004
394 LACTIC ACIDOSIS 13 0.0004
395 HEPATIC ENZYME ABNORMAL 2 0.0004
396 RASH MACULAR 14 0.0004
397 EYE IRRITATION 23 0.0004
398 DERMATOMYOSITIS 1 0.0004
399 TOE AMPUTATION 2 0.0004
400 DYSLIPIDAEMIA 2 0.0004
401 DRUG LEVEL DECREASED 4 0.0004
402 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
403 DRUG ADMINISTRATION ERROR 12 0.0004
404 ENDOCARDITIS 2 0.0004
405 TREATMENT NONCOMPLIANCE 21 0.0004
406 MULTIPLE ALLERGIES 3 0.0004
407 WEIGHT FLUCTUATION 4 0.0004
408 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
409 PARTIAL SEIZURES 2 0.0004
410 CONDITION AGGRAVATED 116 0.0004
411 PAIN 234 0.0004
412 JOINT DISLOCATION 4 0.0004
413 ANIMAL BITE 1 0.0004
414 ABDOMINAL DISTENSION 39 0.0004
415 ABDOMINAL MASS 1 0.0004
416 STENT PLACEMENT 3 0.0004
417 BREAST SWELLING 1 0.0004
418 INTESTINAL OBSTRUCTION 14 0.0004
419 FRUSTRATION TOLERANCE DECREASED 3 0.0004
420 PRODUCT RESIDUE PRESENT 2 0.0004
421 GINGIVITIS 2 0.0004
422 BLOOD SODIUM INCREASED 1 0.0004
423 CLUMSINESS 1 0.0004
424 ASTHENOPIA 2 0.0004
425 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
426 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
427 EOSINOPHILIC OESOPHAGITIS 1 0.0004
428 SKIN INFECTION 4 0.0004
429 JOINT SWELLING 43 0.0004
430 PRODUCT QUALITY ISSUE 48 0.0004
431 PERONEAL NERVE PALSY 2 0.0004
432 DUODENAL ULCER HAEMORRHAGE 1 0.0003
433 SKIN IRRITATION 16 0.0003
434 PARAESTHESIA ORAL 5 0.0003
435 SKIN SWELLING 3 0.0003
436 ESCHERICHIA SEPSIS 1 0.0003
437 LOCAL SWELLING 6 0.0003
438 SKIN WARM 2 0.0003
439 ANHEDONIA 9 0.0003
440 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
441 NO ADVERSE EVENT 62 0.0003
442 ARTHROPATHY 19 0.0003
443 MEDICATION ERROR 19 0.0003
444 HYPERTRIGLYCERIDAEMIA 2 0.0003
445 HEADACHE 214 0.0003
446 IMMUNOSUPPRESSION 3 0.0003
447 PURPURA 3 0.0003
448 RESPIRATORY RATE INCREASED 3 0.0003
449 SINUS HEADACHE 2 0.0003
450 WRONG DRUG ADMINISTERED 3 0.0003
451 SOMNOLENCE 67 0.0003
452 OEDEMA 18 0.0003
453 CEREBROVASCULAR DISORDER 1 0.0003
454 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
455 BONE MARROW DISORDER 1 0.0003
456 CRANIOCEREBRAL INJURY 1 0.0003
457 EMERGENCY CARE 1 0.0003
458 OSTEOPENIA 5 0.0003
459 INFLAMMATION 17 0.0003
460 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
461 RETCHING 7 0.0003
462 DYSCHEZIA 1 0.0003
463 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
464 DIASTOLIC DYSFUNCTION 1 0.0003
465 PIGMENTATION DISORDER 2 0.0003
466 DEVICE LEAKAGE 14 0.0003
467 INFUSION SITE EXTRAVASATION 2 0.0003
468 DRUG INEFFECTIVE 423 0.0003
469 EXTRA DOSE ADMINISTERED 13 0.0003
470 PRE-EXISTING CONDITION IMPROVED 2 0.0003
471 BLEPHAROSPASM 2 0.0003
472 STEVENS-JOHNSON SYNDROME 7 0.0003
473 TOOTH DISORDER 7 0.0003
474 FATIGUE 244 0.0003
475 CUSHINGOID 1 0.0003
476 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2 0.0003
477 PLATELET COUNT INCREASED 4 0.0003
478 PRODUCT USE IN UNAPPROVED INDICATION 76 0.0003
479 INFLAMMATORY BOWEL DISEASE 3 0.0003
480 POLYP 2 0.0003
481 BODY TEMPERATURE DECREASED 3 0.0003
482 SKIN DISCOLOURATION 14 0.0003
483 HYPOGAMMAGLOBULINAEMIA 2 0.0003
484 WALKING AID USER 2 0.0003
485 PRODUCT FORMULATION ISSUE 2 0.0003
486 SKIN MASS 2 0.0003
487 SPINAL FRACTURE 6 0.0003
488 HYPERTENSION 62 0.0003
489 MOBILITY DECREASED 21 0.0003
490 DEPRESSION SUICIDAL 1 0.0003
491 DIVERTICULITIS 8 0.0003
492 INCONTINENCE 3 0.0003
493 HAND FRACTURE 2 0.0003
494 DYSPNOEA 159 0.0003
495 APPENDICECTOMY 1 0.0003
496 LETHARGY 16 0.0003
497 APPARENT DEATH 1 0.0003
498 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
499 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
500 MAJOR DEPRESSION 2 0.0003
501 AMYLASE INCREASED 1 0.0003
502 CARDIAC DYSFUNCTION 1 0.0003
503 BONE DENSITY ABNORMAL 1 0.0003
504 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
505 AUTOIMMUNE THYROIDITIS 1 0.0003
506 FLATULENCE 15 0.0003
507 SCAB 3 0.0003
508 LIPASE INCREASED 2 0.0003
509 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
510 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
511 SPLENOMEGALY 3 0.0003
512 DEVICE DELIVERY SYSTEM ISSUE 7 0.0003
513 ARTHRITIS 20 0.0003
514 DISABILITY 5 0.0003
515 CHOLECYSTITIS 3 0.0003
516 GINGIVAL PAIN 2 0.0003
517 CYSTITIS 8 0.0003
518 RASH ERYTHEMATOUS 12 0.0003
519 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
520 ENURESIS 1 0.0002
521 ABNORMAL FAECES 2 0.0002
522 ARTHRITIS BACTERIAL 1 0.0002
523 ESCHERICHIA INFECTION 2 0.0002
524 DRUG DOSE OMISSION 40 0.0002
525 EXPIRED PRODUCT ADMINISTERED 8 0.0002
526 DYSPNOEA EXERTIONAL 9 0.0002
527 DERMATITIS ALLERGIC 3 0.0002
528 THERAPY INTERRUPTED 17 0.0002
529 PAIN IN EXTREMITY 69 0.0002
530 VITAMIN D DECREASED 2 0.0002
531 SKIN HYPERPIGMENTATION 2 0.0002
532 CARDIAC OPERATION 2 0.0002
533 BLOOD MAGNESIUM DECREASED 2 0.0002
534 BALANCE DISORDER 20 0.0002
535 NODULE 3 0.0002
536 BLOOD PRESSURE INCREASED 35 0.0002
537 URINE OUTPUT DECREASED 2 0.0002
538 CONTUSION 22 0.0002
539 DYSPHEMIA 1 0.0002
540 TOOTH INFECTION 3 0.0002
541 LYMPHOCYTE COUNT DECREASED 4 0.0002
542 EYE HAEMORRHAGE 3 0.0002
543 MALIGNANT MELANOMA 3 0.0002
544 THIRST 4 0.0002
545 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
546 GASTROINTESTINAL INFECTION 2 0.0002
547 CHROMATURIA 5 0.0002
548 HEART RATE IRREGULAR 5 0.0002
549 DRUG EFFECT DELAYED 1 0.0002
550 C-REACTIVE PROTEIN INCREASED 8 0.0002
551 PRODUCT AVAILABILITY ISSUE 5 0.0002
552 ABDOMINAL HERNIA 1 0.0002
553 EXOSTOSIS 2 0.0002
554 SKIN LESION 6 0.0002
555 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
556 IRON DEFICIENCY ANAEMIA 2 0.0002
557 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
558 PERICARDIAL EFFUSION 5 0.0002
559 PRODUCT DISTRIBUTION ISSUE 2 0.0002
560 HEPATIC STEATOSIS 4 0.0002
561 CARPAL TUNNEL SYNDROME 3 0.0002
562 SQUAMOUS CELL CARCINOMA 2 0.0002
563 HOT FLUSH 16 0.0002
564 SEASONAL ALLERGY 3 0.0002
565 DEVICE ISSUE 19 0.0002
566 FOOT FRACTURE 4 0.0002
567 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38 0.0002
568 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
569 ABDOMINAL PAIN 49 0.0002
570 PRODUCT PACKAGING ISSUE 2 0.0002
571 SYNCOPE 21 0.0002
572 PARAESTHESIA 33 0.0002
573 LOCALISED INFECTION 5 0.0002
574 DIZZINESS POSTURAL 2 0.0002
575 GASTROENTERITIS 3 0.0002
576 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
577 SKIN HAEMORRHAGE 3 0.0002
578 DIABETIC NEUROPATHY 1 0.0002
579 ANEURYSM 1 0.0002
580 UPPER LIMB FRACTURE 4 0.0002
581 DRY EYE 10 0.0002
582 SALIVARY HYPERSECRETION 2 0.0002
583 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
584 PRODUCT PHYSICAL ISSUE 4 0.0002
585 DRUG TOLERANCE 1 0.0002
586 DRUG DISPENSING ERROR 3 0.0002
587 NEPHROLITHIASIS 9 0.0002
588 SLUGGISHNESS 2 0.0002
589 AMMONIA INCREASED 1 0.0002
590 NASOPHARYNGITIS 36 0.0002
591 MUSCULOSKELETAL CHEST PAIN 3 0.0002
592 RHEUMATOID ARTHRITIS 22 0.0002
593 SKIN ULCER 5 0.0002
594 EXPOSURE VIA SKIN CONTACT 5 0.0002
595 BASAL CELL CARCINOMA 3 0.0002
596 FOLLICULITIS 2 0.0002
597 CATATONIA 1 0.0002
598 PRODUCT USE COMPLAINT 3 0.0002
599 KNEE ARTHROPLASTY 4 0.0002
600 OCULAR HYPERAEMIA 9 0.0002
601 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
602 EAR INFECTION 5 0.0002
603 BREAST PAIN 2 0.0002
604 BRUXISM 1 0.0002
605 BACK PAIN 43 0.0002
606 BEHAVIOUR DISORDER 1 0.0002
607 CHEILITIS 1 0.0002
608 CATARACT 11 0.0002
609 ERYTHEMA OF EYELID 1 0.0002
610 LIMB INJURY 5 0.0002
611 SKIN LACERATION 2 0.0002
612 BACK INJURY 2 0.0002
613 PRODUCT PRESCRIBING ISSUE 4 0.0002
614 WOUND INFECTION 2 0.0002
615 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
616 CHOKING SENSATION 1 0.0002
617 FOOT DEFORMITY 2 0.0002
618 WOUND 5 0.0002
619 GAIT DISTURBANCE 34 0.0002
620 VISION BLURRED 24 0.0002
621 MUSCULOSKELETAL DISCOMFORT 3 0.0002
622 OFF LABEL USE 152 0.0002
623 ENTEROCOLITIS 1 0.0002
624 DEHYDRATION 23 0.0002
625 SURGERY 10 0.0002
626 BRADYKINESIA 1 0.0002
627 URINARY INCONTINENCE 5 0.0002
628 BACTERAEMIA 2 0.0002
629 MACULAR DEGENERATION 2 0.0002
630 RESPIRATORY DISORDER 5 0.0002
631 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
632 GASTROENTERITIS VIRAL 3 0.0002
633 BLOOD PRESSURE DECREASED 11 0.0002
634 NOCTURIA 2 0.0002
635 FOETAL GROWTH RESTRICTION 1 0.0002
636 DERMATITIS ACNEIFORM 1 0.0002
637 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002
638 PRURITUS 62 0.0002
639 CHOLANGITIS 1 0.0002
640 CYST 2 0.0002
641 TOOTH EXTRACTION 2 0.0002
642 RASH 70 0.0002
643 OXYGEN SATURATION DECREASED 9 0.0002
644 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
645 CELLULITIS 8 0.0002
646 WEIGHT DECREASED 44 0.0002
647 FEELING JITTERY 3 0.0002
648 DRY SKIN 21 0.0002
649 SLEEP APNOEA SYNDROME 3 0.0002
650 HERPES ZOSTER 9 0.0002
651 INTRAOCULAR PRESSURE INCREASED 2 0.0002
652 ENTERITIS 1 0.0002
653 HAEMOGLOBIN DECREASED 16 0.0002
654 INFUSION SITE PAIN 2 0.0002
655 NIGHT SWEATS 5 0.0002
656 PRESCRIBED OVERDOSE 3 0.0002
657 HIATUS HERNIA 2 0.0002
658 HAEMORRHOIDS 3 0.0002
659 ORAL HERPES 3 0.0002
660 NASAL CONGESTION 9 0.0002
661 INFECTION 22 0.0002
662 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
663 APPETITE DISORDER 1 0.0002
664 VIRAL INFECTION 5 0.0002
665 FALL 50 0.0002
666 CARDIAC FAILURE ACUTE 1 0.0001
667 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
668 QUALITY OF LIFE DECREASED 2 0.0001
669 INCORRECT DOSE ADMINISTERED 34 0.0001
670 BREAST MASS 1 0.0001
671 EYE PRURITUS 5 0.0001
672 BRONCHITIS 11 0.0001
673 SINUS CONGESTION 2 0.0001
674 RASH PRURITIC 8 0.0001
675 NEUROPATHY PERIPHERAL 14 0.0001
676 PALLOR 4 0.0001
677 IMPAIRED GASTRIC EMPTYING 2 0.0001
678 BLOOD TESTOSTERONE DECREASED 1 0.0001
679 TREATMENT FAILURE 12 0.0001
680 TOOTH LOSS 3 0.0001
681 NIGHTMARE 5 0.0001
682 DELIRIUM 5 0.0001
683 ANXIETY 41 0.0001
684 ACUTE KIDNEY INJURY 22 0.0001
685 ABDOMINAL DISCOMFORT 24 0.0001
686 INSOMNIA 38 0.0001
687 DEVICE OCCLUSION 2 0.0001
688 DECREASED APPETITE 33 0.0001
689 ARTHRALGIA 59 0.0001
690 MUSCLE SPASMS 26 0.0001
691 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
692 DIALYSIS 2 0.0001
693 DIVERTICULUM 1 0.0001
694 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
695 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
696 WEIGHT INCREASED 31 0.0001
697 FAECES DISCOLOURED 3 0.0001
698 MYELODYSPLASTIC SYNDROME 2 0.0001
699 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
700 COVID-19 24 0.0001
701 VOMITING 64 0.0001
702 FEBRILE NEUTROPENIA 9 0.0001
703 CEREBRAL DISORDER 1 0.0001
704 ARTHROPOD BITE 1 0.0001
705 BONE LOSS 2 0.0001
706 BREAST TENDERNESS 1 0.0001
707 LACRIMATION INCREASED 4 0.0001
708 THERAPEUTIC RESPONSE DECREASED 8 0.0001
709 HEART RATE INCREASED 13 0.0001
710 DISCOMFORT 8 0.0001
711 LYMPHOMA 2 0.0001
712 ANKLE FRACTURE 2 0.0001
713 CONGENITAL ANOMALY 1 0.0001
714 TENDONITIS 2 0.0001
715 DELUSION 2 0.0001
716 BONE DENSITY DECREASED 4 0.0001
717 AFFECTIVE DISORDER 1 0.0001
718 HALLUCINATION, AUDITORY 2 0.0001
719 SKIN BURNING SENSATION 9 0.0001
720 NECK PAIN 7 0.0001
721 EYE PAIN 7 0.0001
722 MUSCLE TIGHTNESS 2 0.0001
723 DEPRESSION 28 0.0001
724 BACK DISORDER 2 0.0001
725 DECUBITUS ULCER 1 0.0001
726 EYE DISORDER 4 0.0001
727 NAUSEA 95 0.0001
728 EOSINOPHIL COUNT INCREASED 1 0.0001
729 TYPE 2 DIABETES MELLITUS 4 0.0001
730 CANDIDA INFECTION 2 0.0001
731 FLUID RETENTION 6 0.0001
732 CIRCULATORY COLLAPSE 2 0.0001
733 DEVICE DEFECTIVE 2 0.0001
734 DEAFNESS 3 0.0001
735 SYRINGE ISSUE 2 0.0001
736 FEELING HOT 7 0.0001
737 GASTRITIS 3 0.0001
738 HYPOAESTHESIA 17 0.0001
739 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
740 RENAL FAILURE 15 0.0001
741 GALLBLADDER DISORDER 2 0.0001
742 CEREBRAL HAEMORRHAGE 4 0.0001
743 MALAISE 49 0.0001
744 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
745 PAIN OF SKIN 3 0.0001
746 THERAPY NON-RESPONDER 5 0.0001
747 TOOTHACHE 2 0.0001
748 OSTEOMYELITIS 2 0.0001
749 HYPERGLYCAEMIA 4 0.0001
750 BRAIN NEOPLASM 1 0.0001
751 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
752 PROCEDURAL PAIN 3 0.0001
753 BREAST CANCER STAGE I 1 0.0001
754 EYE SWELLING 4 0.0001
755 RENAL DISORDER 5 0.0001
756 INFUSION RELATED REACTION 7 0.0001
757 INTENTIONAL DOSE OMISSION 3 0.0001
758 HAEMORRHAGE 11 0.0001
759 MUSCULOSKELETAL DISORDER 2 0.0001
760 EYE INFLAMMATION 1 0.0001
761 POST PROCEDURAL COMPLICATION 2 0.0001
762 DRUG PRESCRIBING ERROR 2 0.0001
763 ACUTE RESPIRATORY FAILURE 2 0.0001
764 ATELECTASIS 1 0.0001
765 HYPOGLYCAEMIA 5 0.0001
766 NEEDLE ISSUE 3 0.0001
767 EAR PAIN 2 0.0001
768 AUTOIMMUNE DISORDER 1 0.0001
769 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
770 COELIAC DISEASE 1 0.0001
771 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
772 ACUTE MYOCARDIAL INFARCTION 3 0.0001
773 SINUS DISORDER 2 0.0001
774 FEELING ABNORMAL 24 0.0001
775 EMPHYSEMA 1 0.0001
776 PRODUCT ADMINISTRATION ERROR 2 0.0001
777 STOMATITIS 6 0.0001
778 EAR DISCOMFORT 1 0.0001
779 EMOTIONAL DISORDER 3 0.0001
780 OSTEOPOROSIS 4 0.0001
781 INFLUENZA LIKE ILLNESS 8 0.0001
782 HYPERSENSITIVITY 18 0.0001
783 PULMONARY HYPERTENSION 2 0.0001
784 ECZEMA 5 0.0001
785 DERMATITIS ATOPIC 5 0.0001
786 HYPOTENSION 19 0.0001
787 DYSGEUSIA 7 0.0001
788 URINARY TRACT INFECTION 16 0.0001
789 BODY HEIGHT DECREASED 1 0.0001
790 MOVEMENT DISORDER 3 0.0001
791 DECREASED ACTIVITY 1 0.0001
792 SEPTIC SHOCK 4 0.0001
793 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
794 CHOLELITHIASIS 3 0.0001
795 IMPAIRED HEALING 3 0.0001
796 BLOOD GLUCOSE FLUCTUATION 1 0.0001
797 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
798 STAPHYLOCOCCAL INFECTION 3 0.0001
799 EMOTIONAL DISTRESS 11 0.0001
800 URINARY RETENTION 3 0.0001
801 HEPATOTOXICITY 2 0.0001
802 ORAL PAIN 2 0.0001
803 RASH PAPULAR 2 0.0001
804 SNEEZING 2 0.0001
805 THROAT IRRITATION 4 0.0001
806 HEPATIC ENZYME INCREASED 6 0.0001
807 SINUSITIS 9 0.0001
808 INJECTION SITE BRUISING 7 0.0001
809 HAEMATURIA 3 0.0001
810 GASTRIC DISORDER 3 0.0001
811 ELECTROLYTE IMBALANCE 1 0.0001
812 PALPITATIONS 10 0.0001
813 DYSPHAGIA 8 0.0001
814 PRODUCTIVE COUGH 4 0.0001
815 DIARRHOEA 54 0.0001
816 BLOOD GLUCOSE DECREASED 4 0.0001
817 BURSITIS 1 0.0001
818 ADRENAL INSUFFICIENCY 1 0.0001
819 PANIC ATTACK 3 0.0001
820 ACCIDENTAL OVERDOSE 3 0.0001
821 OSTEONECROSIS OF JAW 2 0.0001
822 HEPATIC FUNCTION ABNORMAL 3 0.0001
823 PNEUMONIA ASPIRATION 2 0.0001
824 LEUKOPENIA 4 0.0001
825 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
826 COLITIS 3 0.0001
827 ABDOMINAL PAIN LOWER 2 0.0001
828 HYPOPHAGIA 2 0.0001
829 HOSPITALISATION 12 0.0001
830 ADVERSE DRUG REACTION 7 0.0001
831 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
832 URTICARIA 13 0.0001
833 RASH GENERALISED 2 0.0001
834 DIPLOPIA 2 0.0001
835 RESPIRATORY TRACT INFECTION 2 0.0001
836 PRODUCT DOSE OMISSION 5 0.0001
837 MYALGIA 13 0.0001
838 JOINT STIFFNESS 2 0.0001
839 DIZZINESS 38 0.0001
840 BEDRIDDEN 1 0.0001
841 ANKYLOSING SPONDYLITIS 1 0.0001
842 ABNORMAL BEHAVIOUR 3 0.0001
843 JAUNDICE 2 0.0001
844 BLOOD BILIRUBIN INCREASED 2 0.0001
845 DEVICE BREAKAGE 3 0.0001
846 DYSKINESIA 3 0.0001
847 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
848 CORONARY ARTERY OCCLUSION 1 0.0001
849 MEMORY IMPAIRMENT 10 0.0001
850 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
851 FEELING COLD 2 0.0001
852 RECTAL HAEMORRHAGE 3 0.0001
853 ACCIDENTAL UNDERDOSE 1 0.0001
854 VAGINAL HAEMORRHAGE 3 0.0001
855 DYSPHONIA 4 0.0001
856 CHEST DISCOMFORT 7 0.0001
857 ILLNESS 7 0.0001
858 COLON CANCER 1 0.0001
859 BLOOD POTASSIUM DECREASED 2 0.0001
860 ALOPECIA 13 0.0001
861 UNEVALUABLE EVENT 5 0.0001
862 BLOOD COUNT ABNORMAL 1 0.0001
863 PLATELET COUNT DECREASED 7 0.0001
864 VERTIGO 4 0.0001
865 ADVERSE EVENT 6 0.0001
866 HYPOKALAEMIA 3 0.0001
867 OROPHARYNGEAL PAIN 6 0.0001
868 LIMB DISCOMFORT 2 0.0001
869 INJECTION SITE ERYTHEMA 8 0.0001
870 EJECTION FRACTION DECREASED 1 0.0001
871 CYANOSIS 1 0.0001
872 HEAD INJURY 2 0.0001
873 HYPOTHYROIDISM 2 0.0001
874 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
875 HIP FRACTURE 2 0.0001
876 RHINORRHOEA 4 0.0001
877 ATRIAL FIBRILLATION 6 0.0001
878 MUSCULAR WEAKNESS 7 0.0001
879 BLOOD POTASSIUM INCREASED 1 0.0001
880 DEEP VEIN THROMBOSIS 4 0.0001
881 SEIZURE 7 0.0001
882 CYTOMEGALOVIRUS INFECTION 1 0.0001
883 COAGULOPATHY 1 0.0001
884 AGGRESSION 3 0.0001
885 GAIT INABILITY 2 0.0001
886 BLOOD UREA INCREASED 1 0.0001
887 RENAL IMPAIRMENT 5 0.0001
888 DISEASE PROGRESSION 7 0.0001
889 THERAPY CESSATION 3 0.0001
890 INJECTION SITE REACTION 4 0.0001
891 NEOPLASM PROGRESSION 2 0.0001
892 MUSCULOSKELETAL PAIN 3 0.0001
893 DEVICE USE ISSUE 1 0.0001
894 INJURY 4 0.0001
895 BRADYCARDIA 3 0.0001
896 LYMPHADENOPATHY 2 0.0001
897 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
898 COMPLICATION OF DEVICE REMOVAL 1 0.0001
899 INJECTION SITE MASS 2 0.0001
900 INFLUENZA 6 0.0001
901 MIGRAINE 5 0.0001
902 PRODUCT SUBSTITUTION ISSUE 3 0.0001
903 PLASMA CELL MYELOMA 2 0.0001
904 CHILLS 6 0.0001
905 BLOOD PRESSURE ABNORMAL 1 0.0001
906 IRRITABILITY 3 0.0000
907 ILL-DEFINED DISORDER 3 0.0000
908 PSORIATIC ARTHROPATHY 2 0.0000
909 FLUSHING 5 0.0000
910 DEATH 42 0.0000
911 POLLAKIURIA 2 0.0000
912 ROAD TRAFFIC ACCIDENT 2 0.0000
913 EATING DISORDER 1 0.0000
914 LOSS OF CONSCIOUSNESS 6 0.0000
915 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
916 AMNESIA 3 0.0000
917 SWELLING FACE 3 0.0000
918 MENTAL DISORDER 2 0.0000
919 PSORIASIS 6 0.0000
920 ANGIOEDEMA 2 0.0000
921 NEOPLASM MALIGNANT 3 0.0000
922 INJECTION SITE PRURITUS 3 0.0000
923 TINNITUS 2 0.0000
924 DEVICE MALFUNCTION 3 0.0000
925 ARRHYTHMIA 2 0.0000
926 COLORECTAL CANCER 2 0.0000
927 MULTIPLE SCLEROSIS 2 0.0000
928 DIABETIC KETOACIDOSIS 1 0.0000
929 CEREBROVASCULAR ACCIDENT 7 0.0000
930 RESPIRATORY FAILURE 3 0.0000
931 FIBROMYALGIA 1 0.0000
932 AGITATION 3 0.0000
933 DYSPEPSIA 4 0.0000
934 ABASIA 1 0.0000
935 HALLUCINATION 3 0.0000
936 ACNE 3 0.0000
937 CHRONIC KIDNEY DISEASE 3 0.0000
938 INJECTION SITE PAIN 12 0.0000
939 HYPERHIDROSIS 5 0.0000
940 NERVOUSNESS 2 0.0000
941 DEPRESSED MOOD 2 0.0000
942 CHEST PAIN 7 0.0000
943 CARDIAC FAILURE 3 0.0000
944 OVERDOSE 8 0.0000
945 HAEMATOCHEZIA 2 0.0000
946 ABNORMAL DREAMS 1 0.0000
947 DYSSTASIA 1 0.0000
948 BLADDER CANCER 2 0.0000
949 TACHYCARDIA 3 0.0000
950 APHASIA 1 0.0000
951 EPILEPSY 1 0.0000
952 DRUG-INDUCED LIVER INJURY 1 0.0000
953 BLOOD GLUCOSE INCREASED 6 0.0000
954 DEVICE DIFFICULT TO USE 2 0.0000
955 ANGER 1 0.0000
956 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
957 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
958 MYOCARDIAL INFARCTION 5 0.0000
959 CRYING 1 0.0000
960 DYSURIA 1 0.0000
961 DYSARTHRIA 1 0.0000
962 INJECTION SITE HAEMORRHAGE 2 0.0000
963 CARDIAC FAILURE CONGESTIVE 2 0.0000
964 BLINDNESS 1 0.0000
965 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
966 DEVICE DISLOCATION 1 0.0000
967 PRODUCT STORAGE ERROR 2 0.0000
968 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
969 COLITIS ULCERATIVE 1 0.0000
970 SUICIDAL IDEATION 2 0.0000
971 COGNITIVE DISORDER 1 0.0000
972 CARDIAC DISORDER 2 0.0000
973 DRUG EFFECT DECREASED 1 0.0000
974 THROMBOCYTOPENIA 2 0.0000
975 BONE PAIN 1 0.0000
976 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
977 VISUAL IMPAIRMENT 2 0.0000
978 NEUTROPENIA 2 0.0000
979 EPISTAXIS 1 0.0000
980 CONFUSIONAL STATE 2 0.0000
981 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
982 CARDIAC ARREST 1 0.0000
983 TOXICITY TO VARIOUS AGENTS 2 0.0000
984 DRUG WITHDRAWAL SYNDROME 1 0.0000
985 BREAST CANCER 1 0.0000
986 DRUG INTERACTION 1 0.0000